VetDC Acquires Veterinary Rights For Cancer Molecule
March 2, 2011
VetDC Inc. reported today that it has acquired North American veterinary rights to Gilead Sciences Inc.’s investigational molecule, GS 9219, for use in animal cancer. VetDC is a Colorado State University startup based in Fort Collins, Colo. The product development company focuses on in-licensing, developing and commercializing human biomedical technologies for use in dogs… Continue reading...